Summary
Somatostatin release from the isolated pancreas of 3 normal and 6 streptozotocin diabetic dogs has been measured in response to various stimuli to determine whether abnormalities in somatostatin release are present in the diabetic pancreas. Simultaneous measurement of glucagon secretion was also made. In the pancreas from normal dogs increases in perfusate glucose from 25 to 200 mg/100 ml induced a 2–3 fold increase in somatostatin release and a two thirds decrease in glucagon secretion. In contrast, in the diabetic pancreas glucose caused no change in the secretion of the two hormones. In the diabetic pancreas addition of insulin to the perfusate (25,000 μU/ml) for periods from 10 to 75 minutes aimed at restoring normal extracellular insulin levels in the islets failed to restore either somatostatin or glucagon secretion to normal. In contradistinction to the lack of effect of glucose, the somatostatin and glucagon responses to arginine (5 mmol/l), isoproterenol (2 ng/ml) and calcium (5 mmol/l) were normal in the diabetic pancreas. The data suggests the presence of a selective glucoreceptor abnormality of the D as well as of B and A cells in the streptozotocin diabetic dog.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alberti, K. G. M. M., Christensen, S. E., Iversen, J., Seyer-Hansen, K., Christensen, N. J., Hansen, Aa. P., Lundbæk, K., Ørskov, H.: Inhibition of insulin secretion by somatostatin. Lancet1973 II, 1299–1301
Iversen, J.: Inhibition of pancreatic glucagon release by somatostatin: In vitro. Scand. J. Clin. Lab. Invest.33, 125–129 (1974)
Adrian, T. E., Bloom, S. R., Hermansen, K., Iversen, J.: Pancreatic polypeptide secretion from the isolated, perfused canine pancreas. Diabetologia14, 413–417 (1978)
Christensen, S. E., Hansen, Aa. P., Iversen, J., Lundbaek, K., Ørskov, H., Seyer-Hansen, K.: Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: Modifications of glucagon and insulin release. Scand. J. Clin. Lab. Invest.34, 321–325 (1974)
Schauder, P., McIntosh, C., Arends, G., Arnold, R., Frerichs, H., Creutzfeldt, W.: Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett.68, 225–227 (1976)
Ipp, E., Dobbs, R. E., Arimura, A., Vale, W., Harris, V., Unger, R. H.: Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J. Clin. Invest.60, 760–765 (1977)
Hermansen, K., Christensen, S. E., Ørskov, H.: Characterization of somatostatin release from the pancreas. The role of calcium and acetylcholine. Diabetologia16, 261–266 (1979)
Patton, G. S., Dobbs, R., Orci, L., Weil, W., Unger, R. H.: Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon. Metabolism25, 1499–1500 (1976)
Schauder, P., McIntosh, C., Ebert, R., Arends, J., Arnold, R., Frerichs, H., Creutzfeldt, W.: Insulin and somatostatin release and cAMP content of rat pancreatic islets stimulated by glucose and glucagon. Diabetologia12, 417 (1976)
Schusdziarra, V., Dobbs, R. E., Harris, V., Unger, R. H.: Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. FEBS Lett.81, 69–72 (1977)
Orci, L., Baetens, P., Dubois, M. P., Rufener, C.: Evidence for the D-cell of pancreas secreting somatostatin. Horm. Metab. Res.7, 400–402 (1975)
Patel, Y., Weir, G.: Increased somatostatin content of islets from streptozotocin-diabetic rats. Clin. Endocrinol. (Oxf.)5, 191–194 (1976)
Orci, L., Baetens, D., Rufener, C., Amherdt, M., Ravazzola, M., Studer, P., Malaisse-Lagae, F., Unger, R. H.: Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc. Natl. Acad. Sci. USA73, 1338–1342 (1976)
Iversen, J., Miles, D. W.: Evidence for a feed-back inhibition of insulin on insulin secretion in the isolated perfused canine pancreas. Diabetes20, 1–9 (1971)
Ørskov, H., Thomsen, H. G., Yde, H.: Wick-chromatography for rapid and reliable immunoassay of insulin, glucagon, and growth hormone. Nature219, 193–195 (1968)
Christensen, N. J.: Notes on the glucose oxidase method. Scand. J. Clin. Lab. Invest.19, 379–384 (1967)
Laube, H., Fussganger, R. D., Maier, V., Pfeiffer, E. F.: Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db/db). Diabetologia9, 400–402 (1973)
Buchanan, K. D., Mawhinney, W. A. A.: Glucagon release from isolated pancreas in streptozotocin treated rats. Diabetes22, 797–800 (1973)
Pagliara, A. S., Stillings, S. N., Haymond, M. W., Hover, B. A., Matschinsky, F. M.: Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats. J. Clin. Invest.55, 244–255 (1975)
Aydin, I., Raskin, P., Unger, R. H.: The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile diabetes. Diabetologia13, 629–636 (1977)
Patton, G., Ipp, E., Dobbs, R., Orci, L., Vale, W., Unger, R. H.: Pancreatic immunoreactive somatostatin release. Proc. Natl. Acad. Sci. USA74, 2140–2143 (1977)
Schusdziarra, V., Ipp, E., Harris, V., Dobbs, R. E., Raskin, P., Orci, L., Unger, R. H.: Studies of the physiology and pathophysiology of the pancreatic D-cell. Metabolism27, 1227–1232 (1978)
Dunbar, J. C., Walsh, M. F., Foa, P. P.: The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats. Diabetologia14, 53–58 (1978)
Blasquez, E., Munos-Barragan, L., Patton, G. S., Orci, L., Dobbs, R. E., Unger, R. H.: Gastric A-cell function in insulin-deprived depancreatized dogs. Endocrinology99, 1182–1188 (1976)
Buchanan, K. D., Mawhinney, W. A.: Insulin control of glucagon release from insulin-deficient rat islets. Diabetes22, 801–803 (1973)
Samols, E., Harrison, J.: Evidence for a negative insulin-glucagon feedback. Diabetes24 [Suppl. 2], 442 (1975)
Deckert, T., Lauridsen, U. B., Madsen, S. N., Mogensen, P.: Insulin response to glucose, tolbutamide, secretin and isoprenaline in maturity-onset diabetes mellitus. Dan. Med. Bull.19, 222–226 (1972)
Robertson, R. P., Porte, D.: The glucose receptor: a defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J. Clin. Invest.52, 870–876 (1973)
Gerich, J. E., Langlois, M., Noacco, C., Lorenzi, M., Karam, J. H., Forsham, P. H., Gustafson, G.: Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. J. Clin. Invest.58, 320–325 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hermansen, K., Ørskov, H. & Christensen, S.E. Streptozotocin diabetes: A glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia 17, 385–389 (1979). https://doi.org/10.1007/BF01236274
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01236274